Current Opportunities

More information on the use of clinical decision support technologies to identify possible cancer within GP consultations can be found on the NICE website.

What’s involved?

• Completing a short expression of interest form.
• Attending a patient expert induction session with NICE.
• Participating in the committee meeting on Thursday 29 October 2026.
• Sharing personal experiences and perspectives relevant to the topic, usually via a couple of slides, at the committee meeting.

Support available

• Patient experts receive a full induction and support from the People and Communities team.
• Reasonable expenses are paid in line with NICE’s non-staff expenses policy.
• Meetings are usually held online via Zoom.

Key dates

• Expression of interest deadline: 24 Aug 2026
• Patient expert induction: to be arranged around availability
• Committee meeting: 29 October 2026

To find out more or express an interest, please complete the form here: https://nice.welcomesyourfeedback.net/Technologies_for_identifying_possible_cancer

If you have any questions, please contact Helen.Crosbie@nice.org.uk or pact@nice.org.uk.

The most common cancer related emergencies are:

• Unexpected blood clots in the lung (pulmonary embolism)
• Low-risk febrile neutropenia (fever and low immunity)
• New brain lesions
• Hypercalcaemia (high calcium levels)
• Metastatic spinal cord compression with minimal neurological symptoms

The aim of these resources is to help patients and families understand:

• What symptoms to look out for
• What action to take and when to seek help
• What may happen next, including possible assessment and treatment at a local Same Day Emergency Care (SDEC) service

We know that many patients feel more comfortable attending The Christie, and some are unfamiliar with SDEC services. We want to ensure that any information we produce is clear, reassuring and answers the questions that matter most to patients.

You do not need to have experienced one of these specific conditions to take part. Any patient with experience of cancer treatment can provide valuable insights, as anyone affected by cancer may encounter these situations.

If you are interested, please select ‘enquire about opportunity’ and send us an email to gmcancer.voices@nhs.net.

Meetings will take place in-person on a quarterly basis until the end of March 2027. The next few meetings will take place at the Paterson Building at The Christie on the following dates:

23rd June, 1-4pm

15th September, 1-4pm

17th November, 1-4pm

If you are interested in participating in this opportunity or would like more information please contact us through the ‘Enquire About Opportunity’ tab below or email the Cancer Voices email address gmcancer.voices@nhs.net. The lead staff member will arrange an informal phone conversation with you.

Single Queue Diagnostics gives patients the choice to access an appointment sooner by going to a different hospital than their usual hospital. This has been demonstrated to make better use of existing capacity and reduce waiting times significantly (for all patients, not only those able to travel further).

Patient representatives will be asked to attend an online monthly meeting, up to 1 hour, and support the development of patient information leaflets. Meetings are expected to move to fortnightly when drawing closer to ‘go live’ in October 2026. Dates and times of the meetings are still to be determined.

If you are interested in participating in this opportunity or would like more information please contact us through the ‘Enquire About Opportunity’ tab below or email the Cancer Voices email address gmcancer.voices@nhs.net and outline your experience and why you have a particular interest in this project.

Our primary objectives are: reducing time to diagnosis, achieve national cancer targets, streamlining referral-to-treatment pathways and improving patient experience. As a representative, you will work alongside another representative to ensure that the voices of patients and carers are heard and considered in the board’s decisions. Through these efforts, we seek to ensure that cancer patients in GM receive the best possible care with minimal delays, aligning with the broader national strategy for cancer care excellence.

Role Profile – FDS OP TV